全文获取类型
收费全文 | 702868篇 |
免费 | 28699篇 |
国内免费 | 499篇 |
专业分类
耳鼻咽喉 | 7828篇 |
儿科学 | 23419篇 |
妇产科学 | 15506篇 |
基础医学 | 108863篇 |
口腔科学 | 13858篇 |
临床医学 | 60637篇 |
内科学 | 125822篇 |
皮肤病学 | 12547篇 |
神经病学 | 50168篇 |
特种医学 | 28615篇 |
外国民族医学 | 54篇 |
外科学 | 106884篇 |
综合类 | 9899篇 |
现状与发展 | 2篇 |
一般理论 | 108篇 |
预防医学 | 56262篇 |
眼科学 | 14639篇 |
药学 | 50663篇 |
1篇 | |
中国医学 | 1755篇 |
肿瘤学 | 44536篇 |
出版年
2021年 | 3960篇 |
2018年 | 27176篇 |
2017年 | 21043篇 |
2016年 | 23972篇 |
2015年 | 6259篇 |
2014年 | 7909篇 |
2013年 | 11284篇 |
2012年 | 22401篇 |
2011年 | 37962篇 |
2010年 | 28358篇 |
2009年 | 20126篇 |
2008年 | 34830篇 |
2007年 | 38682篇 |
2006年 | 17456篇 |
2005年 | 18406篇 |
2004年 | 19211篇 |
2003年 | 19523篇 |
2002年 | 17250篇 |
2001年 | 22763篇 |
2000年 | 23458篇 |
1999年 | 19151篇 |
1998年 | 5444篇 |
1997年 | 4580篇 |
1996年 | 4485篇 |
1995年 | 4240篇 |
1992年 | 14490篇 |
1991年 | 15946篇 |
1990年 | 16123篇 |
1989年 | 15751篇 |
1988年 | 14392篇 |
1987年 | 14280篇 |
1986年 | 13229篇 |
1985年 | 12755篇 |
1984年 | 9446篇 |
1983年 | 8050篇 |
1982年 | 4221篇 |
1979年 | 8964篇 |
1978年 | 6410篇 |
1977年 | 5173篇 |
1976年 | 5525篇 |
1975年 | 6636篇 |
1974年 | 7464篇 |
1973年 | 7183篇 |
1972年 | 6617篇 |
1971年 | 6330篇 |
1970年 | 5928篇 |
1969年 | 5510篇 |
1968年 | 5189篇 |
1967年 | 4629篇 |
1966年 | 3974篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
An ankylosed tooth can be suitable for obtaining orthodontic anchorage. However, if such a tooth lacks adequate clinical crown height, the anchorage will not be effective. In those situations surgical luxation or restorative crown augmentation is suggested. This case report is about the restorative treatment of an ankylosed, infraoccluded tooth to enhance the anchorage for forced orthodontic eruption of impacted maxillary canines. A crown augmentation in the form of a modified bilayered (sandwich) restoration using GIC, Composite resin and Silver amalgam on left maxillary first molar (26) was successful in sustaining the anchorage for forced eruption and alignment of impacted canines. 相似文献
992.
Najat MA Farsi 《BMC oral health》2007,7(1):15
Background
This study aimed to investigate the signs of oral dryness in relation to different salivary variables and to correlate subjective complaints of oral dryness with salivary flow rate. 相似文献993.
Interleukin 1 mediated acceleration of type II collagen-induced arthritis: effects of anti-inflammatory or anti-arthritic drugs 总被引:1,自引:0,他引:1
We previously demonstrated that treatments with rIL-1 beta accelerated the onset and progression of CIA in mice. In the present study, it was observed that IL-1 also enhanced the development of CIA in rats. Like the mouse model, maximal incidence (80-100%) of arthritis occurred within 7 days after the first treatment with IL-1 in rats. Thus, the acceleration of CIA by IL-1 (IL-1 CIA) may be an improved model for the rapid screening of anti-inflammatory and/or anti-arthritic drugs. As a first step to determining the utility of the IL-1 CIA model as a drug screen, we examined the ability of various known anti-inflammatory and anti-arthritic drugs to modify the IL-1 mediated enhancement of CIA in both rats and mice. The results of these studies showed that when analyzed in the IL-1 CIA model, rats and mice exhibited differences in their responses to several of these drugs. For example, dexamethasone, cyclophosphamide, azathioprine, various non-steroidal anti-inflammatory drugs (NSAIDs) as well as methotrexate were found active in the IL-1 CIA of rats. By contrast, the NSAIDs were found to be less effective in suppressing the IL-1 accelerated disease in mice. In both rats and mice, cyclosporine A and several disease modifying anti-arthritic drugs failed to the prevent the development of CIA that was potentiated by IL-1. Thus, in the IL-1 CIA model NSAIDs appeared to be less active in mice than rats. In conclusion, because of the shorter latent period required for the development of arthritis in the IL-1 treated animals, the IL-1 accelerated CIA model in both mice and rats may be useful for screening anti-inflammatory or anti-arthritic compounds. 相似文献
994.
Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate
S. Adami G. Salvagno G. Guarrera F. Montesanti S. Garavelli S. Rosini V. Lo Cascio 《Calcified tissue international》1986,39(4):226-229
Summary 4-amino-1-hydroxybutylidene-1,1-bis-phosphonate (AHButBP) was given intravenously (2.5–25 mg/day for 4 days) to 14 patients
with Paget's disease of bone, five of whom had been treated with dichloromethylidene bisphosphonate (Cl2MBP) 32 months earlier. In the nine patients who had not been treated previously with bisphosphonates, the short course of
AHButBP induced a suppression of serum alkaline phosphatase and urinary hydroxyproline values down to 30% of initial values.
The biochemical suppression of the disease was sustained for 2–18 months and the time to relapse did correlate to the logarithm
of the dose (P<0.001). In the five patients previously treated for Paget's disease, an apparent resistence to treatment with AHButBP was
observed. However, in these patients both serum alkaline phosphatase and urinary hydroxyproline fell to or even below the
nadir values which had previously been achieved with Cl2MBP, irrespective of the degree of relapse. Thus the degree of suppression of Paget's disease of bone, achievable after treatment
with bisphosphonates, seems to be constant for each patient, such that normal levels of serum alkaline phosphatase and urinary
hydroxyproline cannot usually be attained in patients with extremely active disease. 相似文献
995.
Three hundred and seventeen recent clinical isolates were tested for in vitro susceptibility to the three cephalosporins available in India--cephalexin, cefazolin and cefotaxime by the Kirby--Bauer disc diffusion method. Cefazolin was the most effective cephalosporin against Gram positive cocci (71.8% sensitive) followed by cefotaxime (62.7%) and cephalexin (52.7%). Cefotaxime was very effective against commonly isolated Gram negative bacilli with only 10 (8.8%) isolates being resistant to it while 44 (39%) and 65 (57.5%) were resistant to cefazolin and cephalexin, respectively. All isolates of Pseudomonas aeruginosa were resistant to cephalexin and cefazolin and only 29 (32.6%) were sensitive to cefotaxime. 相似文献
996.
997.
998.
999.
1000.